On February 13, 2018 KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, reported that the Company’s Chairman, President and Chief Executive Officer, Travis Mickle, Ph.D., will present at the RBC Capital Markets 2018 Global Healthcare Conference being held February 21-22, 2018, at the Lotte New York Palace Hotel (Press release, KemPharm, FEB 13, 2018, View Sourcenews-releases/news-release-details/kempharm-present-rbc-capital-markets-2018-global-healthcare" target="_blank" title="View Sourcenews-releases/news-release-details/kempharm-present-rbc-capital-markets-2018-global-healthcare" rel="nofollow">View Source [SID1234523954]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of KemPharm’s presentations are as follows:

Event: RBC Capital Markets 2018 Global Healthcare Conference
Date: Wednesday, February 21, 2018
Time: 4:05 PM (EST)
Location: Lotte New York Palace Hotel, Holmes Room #2, New York, NY
The presentation webcast will available on the Investor Relations section of the KemPharm website at View Source following delivery at the conference.